Notice of Extension of Change in Control Agreement for Executive – Abbott Laboratories

Contract Categories: Human Resources › Change of Control Agreements
Summary

Abbott Laboratories has notified the executive that their Change in Control (CIC) Agreement, which provides financial, health, and welfare benefits in the event of a company change in control, has been extended from its original expiration date of December 31, 2024, to December 31, 2026. No action is required from the executive to maintain participation, and the executive is advised to keep this notice for their records.

Read More Arrow
EX-10.47 4 exhibit1047-noticeofcicext.htm EX-10.47 Document




Exhibit 10.47
[Date]

To: [Executive]

Re: Notice of CIC Extension

Abbott’s Board of Directors recently extended your Change in Control (CIC) Agreement. Its term now continues through December 31, 2026. The CIC Agreement provides you with financial, health and welfare benefits in the event of a Change in Control. No action is required on your part to continue participation in the CIC agreement.

You are hereby notified that your current Change in Control Agreement, which was set to expire on December 31, 2024, has been extended to December 31, 2026.

Please retain a copy of this notification of Extension with your important records.